Tag: progression-free survival

A deep learning model combining pretreatment CT imaging and clinical markers accurately predicts objective tumor response and survival outcomes in ...

A prospective phase II trial protocol outlines plans to evaluate standard first-line immunotherapy regimens in metastatic non-small cell lung cancer ...

A long-term clinical investigation reveals that glioma infiltration into the corticospinal tract significantly elevates postoperative paralysis risks despite surgical electrical ...

A study in JNCCN found that broad-based genomic sequencing before treatment was associated with longer survival in patients with advanced ...

Researchers have identified that the m6A demethylase ALKBH5 stabilizes Notch2 messenger RNA under hypoxic conditions, driving ovarian cancer cell growth, ...

In a Phase 1b clinical trial, the targeted therapy firmonertinib demonstrated durable antitumor activity in patients with uncommon EGFR-mutated non-small ...

A retrospective study of 62 patients found that a high tumor-stroma ratio correlates with aggressive disease features in pure endometrial ...

An exploratory analysis of the randomized MATEO trial found that female patients with advanced esophagogastric adenocarcinoma achieved significantly longer survival ...

A 63-year-old patient with HER2-positive metastatic gastroesophageal junction adenocarcinoma achieved 23 months of progression-free survival on second-line trastuzumab deruxtecan following ...

A retrospective cohort study found that PD-1-based combination therapy was associated with a higher objective response rate and longer progression-free ...

A systematic review and meta-analysis of thirty-four studies links elevated CIP2A expression to significantly worse five-year overall and progression-free survival ...

A descriptive cross-study analysis indirect comparison of the HORIZON trial and LocoMMotion study found similar survival and response rates between ...

A multicenter retrospective study reports that concurrent ACE inhibitor or angiotensin receptor blocker use was associated with improved progression-free survival ...

Clinicians report complete disappearance of extensive liver metastases in a patient with rare, aggressive bladder cancer following whole-liver low-dose radiation ...

A 67-year-old patient with recurrent palatal carcinoma ex pleomorphic adenoma achieved 43 months of progression-free survival following camrelizumab immunotherapy despite ...

Researchers developed a three-lncRNA prognostic signature linked to RNA methylation that reliably stratifies hepatocellular carcinoma survival and therapeutic sensitivity.

An eighty-seven-year-old patient with synchronous intrahepatic cholangiocarcinoma and gastric adenocarcinoma achieved over thirty-eight months of progression-free survival following treatment with ...

A study of advanced non-small cell lung cancer cohorts shows that concurrent TP53 and LRP1B mutations predict improved progression-free survival ...

A retrospective cohort study found that continuing immunotherapy after mild checkpoint inhibitor-associated myocarditis in lung cancer was associated with longer ...

A retrospective multicenter study indicates that escalating radiotherapy doses improves survival outcomes specifically in elderly esophageal squamous cell carcinoma patients ...